InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-1.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Amman Bradford K., Chief Financial Officer. Director active across 1 company, notably Vivos Therapeutics, Inc.. In total, 2 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €9k. Activity tracked since 25 May 2021. The latest transaction was disclosed on 25 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
1,000 shares@ US$5.290.049% mcap50.0% of flowCommon StockSEC:0001493152-21-012902:0
Ideal exit: 19 Feb 2022 (T+270)
1,000 shares@ US$5.2950.0% of flowCommon StockSEC:0001493152-21-012902
Ideal exit: 19 Feb 2022 (T+270)
2 of 2 declarations
About Amman Bradford K.
Bradford K. Amman is the Chief Financial Officer at Vivos Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and risk management. His role is essential in ensuring the financial health and sustainable growth of the organization.
